Are Dopamine Receptor Agonists Neuroprotective in Parkinson's Disease?

Author： Le W-D.   Jankovic J.  

Publisher： Adis International

ISSN： 1170-229X

Source： Drugs & Aging, Vol.18, Iss.6, 2001-06, pp. : 389-396

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dopamine agonists cost effective for cotherapy of Parkinson's disease?

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 332, 2001-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Dopamine D Receptor Agonists: The Way Forward for the Treatment of Parkinson's Disease?

By Vermeulen R.J.   Drukarch B.   Wolters E.C.   Stoof J.C.  

CNS Drugs, Vol. 11, Iss. 2, 1999-02 ,pp. : 83-91

Adis International

Access to resources Recommend Favorite

Can Calcium Antagonists Provide a Neuroprotective Effect in Parkinson's Disease?

By Rodnitzky R.L.  

Drugs, Vol. 57, Iss. 6, 1999-06 ,pp. : 845-849

Adis International

Access to resources Recommend Favorite

Dopamine Agonists in Parkinson’s Disease: What is Their Role in Early Treatment?

By Stocchi F.  

CNS Drugs, Vol. 10, Iss. 3, 1998-09 ,pp. : 159-170

Adis International

Access to resources Recommend Favorite

Sleep Attacks and Dopamine Agonists for Parkinson’s Disease: What is Currently Known?

By Zesiewicz T.A.   Hauser R.A.  

CNS Drugs, Vol. 17, Iss. 8, 2003-01 ,pp. : 593-600

Adis International

Access to resources Recommend Favorite